Search Results Search Sort by RelevanceMost Recent In the Literature Jul 2003 Financial Conflicts of Interest in Biomedical Research Jeremy Spevick Virtual Mentor. 2003;194-196. doi: 10.1001/virtualmentor.2003.5.7.jdsc1-0307. Medical Education Jul 2003 Commercial Support for Continuing Medical Education Murray Kopelow, MD Virtual Mentor. 2003;5(7):255-259. doi: 10.1001/virtualmentor.2003.5.7.medu1-0307. State of the Art and Science Jul 2003 Treating Hypertension Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):265-267. doi: 10.1001/virtualmentor.2003.5.7.cprl1-0307. Policy Forum Jul 2003 Undergraduate and Graduate Medical Education and the Pharmaceutical Industry Greg E. Manship, MDiv, MA Virtual Mentor. 2003;5(7):268-272. doi: 10.1001/virtualmentor.2003.5.7.pfor1-0307. Policy Forum Jul 2003 The PhRMA Code: A New Roadmap for Industry-Physician Interactions Michael Scott Labson, Esq Virtual Mentor. 2003;5(7):273-275. doi: 10.1001/virtualmentor.2003.5.7.pfor2-0307. State of the Art and Science Aug 2003 Antibiotic Treatment of Otitis Media Audiey Kao, MD, PhD Virtual Mentor. 2003;5(8):329-330. doi: 10.1001/virtualmentor.2003.5.8.cprl1-0308. Policy Forum Aug 2003 Prescribing for Behavior Arthur J. Farley, MD Virtual Mentor. 2003;5(8):331-332. doi: 10.1001/virtualmentor.2003.5.8.pfor1-0308. Viewpoint Oct 2003 The Ethics of Electroconvulsive Therapy Loren Mosher, MD and David Cohen, PhD Virtual Mentor. 2003;5(10):463-466. doi: 10.1001/virtualmentor.2003.5.10.oped1-0310 Viewpoint Oct 2003 Ethical Considerations with Electroconvulsive Therapy Richard D. Weiner, MD, PhD Virtual Mentor. 2003;5(10):467-469. doi: 10.1001/virtualmentor.2003.5.10.oped2-0310. Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
In the Literature Jul 2003 Financial Conflicts of Interest in Biomedical Research Jeremy Spevick Virtual Mentor. 2003;194-196. doi: 10.1001/virtualmentor.2003.5.7.jdsc1-0307.
Medical Education Jul 2003 Commercial Support for Continuing Medical Education Murray Kopelow, MD Virtual Mentor. 2003;5(7):255-259. doi: 10.1001/virtualmentor.2003.5.7.medu1-0307.
State of the Art and Science Jul 2003 Treating Hypertension Audiey C. Kao, MD, PhD Virtual Mentor. 2003;5(7):265-267. doi: 10.1001/virtualmentor.2003.5.7.cprl1-0307.
Policy Forum Jul 2003 Undergraduate and Graduate Medical Education and the Pharmaceutical Industry Greg E. Manship, MDiv, MA Virtual Mentor. 2003;5(7):268-272. doi: 10.1001/virtualmentor.2003.5.7.pfor1-0307.
Policy Forum Jul 2003 The PhRMA Code: A New Roadmap for Industry-Physician Interactions Michael Scott Labson, Esq Virtual Mentor. 2003;5(7):273-275. doi: 10.1001/virtualmentor.2003.5.7.pfor2-0307.
State of the Art and Science Aug 2003 Antibiotic Treatment of Otitis Media Audiey Kao, MD, PhD Virtual Mentor. 2003;5(8):329-330. doi: 10.1001/virtualmentor.2003.5.8.cprl1-0308.
Policy Forum Aug 2003 Prescribing for Behavior Arthur J. Farley, MD Virtual Mentor. 2003;5(8):331-332. doi: 10.1001/virtualmentor.2003.5.8.pfor1-0308.
Viewpoint Oct 2003 The Ethics of Electroconvulsive Therapy Loren Mosher, MD and David Cohen, PhD Virtual Mentor. 2003;5(10):463-466. doi: 10.1001/virtualmentor.2003.5.10.oped1-0310
Viewpoint Oct 2003 Ethical Considerations with Electroconvulsive Therapy Richard D. Weiner, MD, PhD Virtual Mentor. 2003;5(10):467-469. doi: 10.1001/virtualmentor.2003.5.10.oped2-0310.
Policy Forum Dec 2020 Guidance for Physicians Who Wish to Influence Policy Development on Determination of Death by Neurologic Criteria Michael A. Rubin, MD, MA Lobbying, maintaining diagnostic skill, participating in national societies, and contributing to robust discourse can influence practice and policy. AMA J Ethics. 2020;22(12):E1033-1037. doi: 10.1001/amajethics.2020.1033.